Entity Common Stock, Shares Outstanding of Indivior Pharmaceuticals, Inc. from 31 Dec 2023 to 31 Jan 2026

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Indivior Pharmaceuticals, Inc. quarterly Entity Common Stock, Shares Outstanding in shares history and change rate from 31 Dec 2023 to 31 Jan 2026.
  • Indivior Pharmaceuticals, Inc. Entity Common Stock, Shares Outstanding for the quarter ending 31 Jan 2026 was 125,065,242.
Source SEC data
View on sec.gov
Entity Common Stock, Shares Outstanding, Quarterly (shares)

Indivior Pharmaceuticals, Inc. Quarterly Entity Common Stock, Shares Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 125,065,242 31 Jan 2026 10-K 26 Feb 2026 2025 FY
Q3 2025 124,853,897 01 Oct 2025 10-Q 30 Oct 2025 2025 Q3
Q2 2025 124,769,820 01 Jul 2025 10-Q 31 Jul 2025 2025 Q2
Q1 2025 124,655,858 01 Mar 2025 10-K 03 Mar 2025 2024 FY
Q4 2023 136,526,357 31 Dec 2023 20-F 06 Mar 2024 2023 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.